Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung cancer cell lines — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung cancer cell lines
Rudolf-Boehm-Institute for Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany; Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany
,
Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany; Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany; Present Address: Targos Molecular Pathology GmbH, Kassel, Germany
,
Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany; Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany; Present Address: Institute for Immunology, Philipps-University Marburg, Marburg, German
,
Walther Straub Institute of Pharmacology and Toxicology, University of Munich (LMU), Munich, Germany; Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research, Munich, Germany
,
Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany; Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany
1 Rudolf-Boehm-Institute for Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany; Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany
2 Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany; Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany; Present Address: Targos Molecular Pathology GmbH, Kassel, Germany
3 Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany; Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany; Present Address: Institute for Immunology, Philipps-University Marburg, Marburg, German
4 Walther Straub Institute of Pharmacology and Toxicology, University of Munich (LMU), Munich, Germany; Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research, Munich, Germany
5 Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany; Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany
In small cell lung cancer cells, various autocrine stimuli lead to the parallel activation of Gq/11 and G 12/13 proteins. The contribution of the Gq/11-PLC- β cascade to the mitogenic effects in SCLC cells is well established, but the relevance of G 12/13 signaling is less explored. While in prostate and breast cancer, G 12/13 activation has been shown previously to promote invasiveness without being involved in cellular proliferation, previous data from our group indicate anti-proliferative effects of G 12/13 knockdown in small cell lung cancer (SCLC) cells. To further investigate the role of G 12/13 -dependent signaling in lung tumor cells, we employed shRNA-mediated targeting of G α 12 , G α 13 , or both, in SCLC and NSCLC cell lines. Lentiviral expression of shRNAs resulted in specific G α 12 and G α 13 knockdown. Of note, upon single knockdown of one family member, no counter-upregulation of the other one was observed. Interestingly, inhibition of proliferation was cell line dependent. In cell lines where knock-down led to antiproliferation, single knockdown of either G α 12 or G α 13 was sufficient to impair proliferation and double knockdown of G α 12 and G α 13 tended not to fur ther increase anti-proliferative effects. Likewise, when single knockdown was insufficient for an inhibition of proliferation, no effects were observed in double knockdowns. Taken together, these findings indicate that both G α 12 and G α 13 affect cellular proliferation individually and interference with one family member is sufficient for anti-tumor effects.
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E.L. and Piccirillo, J. (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. Journal of Clinical Oncology, 24, 4539-4544. http://dx.doi.org/10.1200/JCO.2005.04.4859
Heasley, L.E. (2001) Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene, 20, 1563-1569. http://dx.doi.org/10.1038/sj.onc.1204183
Gudermann, T. and Roelle, S. (2006) Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides. Endocrine-Related Cancer, 13, 1069-1084. http://dx.doi.org/10.1677/erc.1.01302
Grzelinski, M., Pinkenburg, O., Buch, T., Gold, M., Stohr, S., Kalwa, H., Gudermann, T. and Aigner, A. (2010) Critical role of G(alpha)12 and G(alpha)13 for human small cell lung cancer cell proliferation in vitro and tumor growth in vivo. Clinical Cancer Research, 16, 1402-1415. http://dx.doi.org/10.1158/1078-0432.CCR-09-1873
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W.S. and Khvorova, A. (2004) Rational siRNA design for RNA interference. Nature Biotechnology, 22, 326-330. http://dx.doi.org/10.1038/nbt936
Elbashir, S.M., Harborth, J., Weber, K. and Tuschl, T. (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods, 26, 199213.
Smrcka, A.V. (2013) Molecular targeting of Galpha and Gbetagamma subunits: A potential approach for cancer therapeutics. Trends in Pharmacological Sciences, 34, 290-298. http://dx.doi.org/10.1016/j.tips.2013.02.006
Wu, J., Xie, N., Zhao, X., Nice, E.C. and Huang, C. (2012) Dissection of aberrant GPCR signaling in tumorigenesis—A systems biology approach. Cancer Genomics & Proteomics, 9, 37-50.
Entschladen, F., Zanker, K.S. and Powe, D.G. (2011) Heterotrimeric G protein signaling in cancer cells with regard to metastasis formation. Cell Cycle (Georgetown, Tex), 10, 1086-1091.
Spiegelberg, B.D. and Hamm, H.E. (2007) Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription. Current Opinion in Genetics & Development, 17, 40-44. http://dx.doi.org/10.1016/j.gde.2006.12.002
Hepler, J.R. and Gilman, A.G. (1992) G proteins. Trends in Biochemical Sciences, 17, 383-387. http://dx.doi.org/10.1016/0968-0004(92)90005-T
Chan, A.M., Fleming, T.P., McGovern, E.S., Chedid, M., Miki, T. and Aaronson, S.A. (1993) Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product. Molecular and Cellular Biology, 13, 762-768.
Xu, N., Bradley, L., Ambdukar, I. and Gutkind, J.S. (1993) A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells. Proceedings of the National Academy of Sciences of the United States of America, 90, 6741-6745. http://dx.doi.org/10.1073/pnas.90.14.6741
Xu, N., Voyno-Yasenetskaya, T. and Gutkind, J.S. (1994) Potent transforming activity of the G13 alpha subunit defines a novel family of oncogenes. Biochemical and Biophysical Research Communications, 201, 603-609. http://dx.doi.org/10.1006/bbrc.1994.1744
Gardner, J.A., Ha, J.H., Jayaraman, M. and Dhanasekaran, D.N. (2013) The gep proto-oncogene Galpha13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells. Pancreas, 42, 819-828. http://dx.doi.org/10.1097/MPA.0b013e318279c577
Ha, J.H., Ward, J.D., Varadarajalu, L., Kim, S.G. and Dhanasekaran, D.N. (2014) The gep proto-oncogene Galpha12 mediates LPA-stimulated activation of CREB in ovarian cancer cells. Cellular Signalling, 26, 122-132. http://dx.doi.org/10.1016/j.cellsig.2013.08.012
Offermanns, S. and Schultz, G. (1994) What are the functions of the pertussis toxin-insensitive G proteins G12, G13 and Gz? Molecular and Cellular Endocrinology, 100, 71-74. http://dx.doi.org/10.1016/0303-7207(94)90281-X
Kelly, P., Casey, P.J. and Meigs, T.E. (2007) Biologic functions of the G12 subfamily of heterotrimeric g proteins: Growth, migration, and metastasis. Biochemistry, 46, 6677-6687. http://dx.doi.org/10.1021/bi700235f
Dhanasekaran, N. and Dermott, J.M. (1996) Signaling by the G12 class of G proteins. Cellular signalling, 8, 235-245. http://dx.doi.org/10.1016/0898-6568(96)00048-4
Kozasa, T., Hajicek, N., Chow, C.R. and Suzuki, N. (2011) Signalling mechanisms of RhoGTPase regulation by the heterotrimeric G proteins G12 and G13. The Journal of Biochemistry, 150, 357-369. http://dx.doi.org/10.1093/jb/mvr105
Juneja, J., Cushman, I. and Casey, P.J. (2011) G12 signaling through c-Jun NH2-terminal kinase promotes breast cancer cell invasion. PloS one, 6, E26085. http://dx.doi.org/10.1371/journal.pone.0026085
Radhakrishnan, R., Ha, J.H. and Dhanasekaran, D.N. (2010) Mitogenic signaling by the gep oncogene involves the upregulation of s-phase kinase-associated protein 2. Genes & cancer, 1, 1033-1043.
Touge, H., Chikumi, H., Igishi, T., Kurai, J., Makino, H., Tamura, Y., Takata, M., Yoneda, K., Nakamoto, M., Suyama, H., Gutkind, J.S. and Shimizu, E. (2007) Diverse activation states of RhoA in human lung cancer cells: Contribution of G protein coupled receptors. Journal of Clinical Oncology, 30, 709-715.
Rubinson, D.A., Hochster, H.S., Ryan, D.P., Wolpin, B.M., McCleary, N.J., Abrams, T.A., Chan, J.A., Iqbal, S., Lenz, H.J., Lim, D., Rose, J., Bekaii-Saab, T., Chen, H.X., Fuchs, C.S. and Ng, K. (2013) Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients. Investigational New Drugs. http://dx.doi.org/10.1007/s10637-013-9956-5
Beekman, A., Helfrich, B., Bunn, P.A., Jr. and Heasley, L.E. (1998) Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogenactivated protein kinase signaling and inhibits small cell lung cancer growth. Cancer Research, 58, 910-913.
Wittau, N., Grosse, R., Kalkbrenner, F., Gohla, A., Schultz, G. and Gudermann, T. (2000) The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins. Oncogene, 19, 4199-4209. http://dx.doi.org/10.1038/sj.onc.1203777